-
公开(公告)号:US08518999B2
公开(公告)日:2013-08-27
申请号:US11292325
申请日:2005-12-01
申请人: Scott F. Sneddon , John L. Kane , Bradford H. Hirth , Fred Vinick , Shuang Qiao , Sharon R. Nahill , John M. Williams , Hans-Peter Biemann
发明人: Scott F. Sneddon , John L. Kane , Bradford H. Hirth , Fred Vinick , Shuang Qiao , Sharon R. Nahill , John M. Williams , Hans-Peter Biemann
IPC分类号: A61K31/16 , A61K31/4174 , A61K31/436 , A61K31/395 , A61K45/06 , A61P37/06 , C07C233/00 , C07D233/54
CPC分类号: A61K31/53 , C07D233/64 , C07D401/14 , C07D403/14
摘要: The present invention provides compounds which are modulators of TNF-α signaling and methods of use thereof for treating a patient having a TNF-α mediated condition. The compounds can be represented by the following structural formulas:
摘要翻译: 本发明提供了作为TNF-α信号调节剂的化合物及其用于治疗患有TNF-α介导病症的患者的方法。 该化合物可以由以下结构式表示:
-
公开(公告)号:US06969728B2
公开(公告)日:2005-11-29
申请号:US09852965
申请日:2001-05-10
申请人: Scott F. Sneddon , John L. Kane , Bradford H. Hirth , Fred Vinick , Shuang Qiao , Sharon R. Nahill , John M. Williams , Hans-Peter Biemann
发明人: Scott F. Sneddon , John L. Kane , Bradford H. Hirth , Fred Vinick , Shuang Qiao , Sharon R. Nahill , John M. Williams , Hans-Peter Biemann
IPC分类号: C07D295/14 , A61K31/277 , A61K31/405 , A61K31/417 , A61K31/4178 , A61K31/4439 , A61K31/444 , A61K31/498 , A61K31/506 , A61K31/53 , A61K31/5375 , A61K31/5377 , A61P1/04 , A61P1/16 , A61P3/10 , A61P5/14 , A61P7/00 , A61P7/02 , A61P9/10 , A61P9/14 , A61P19/02 , A61P21/04 , A61P25/14 , A61P25/28 , A61P25/32 , A61P29/00 , A61P31/00 , A61P31/04 , A61P31/10 , A61P31/12 , A61P31/18 , A61P33/00 , A61P35/00 , A61P35/02 , A61P37/02 , A61P37/06 , A61P43/00 , C07C255/60 , C07D233/54 , C07D233/64 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/12 , C07D409/12 , C07C233/00 , A61K38/05 , A61K38/06 , A61K38/07
CPC分类号: A61K31/53 , C07D233/64 , C07D401/14 , C07D403/14
摘要: The present invention provides compounds which are modulators of TNF-α signaling and methods of use thereof for treating a patient having a TNF-α mediated condition. The compounds can be represented by the following structural formulas:
摘要翻译: 本发明提供了作为TNF-α信号调节剂的化合物及其用于治疗患有TNF-α介导病症的患者的方法。 该化合物可以由以下结构式表示:
-
3.Novel small molecules with selective cytotoxicity against human microvascular endothelial cell proliferation 审中-公开
标题翻译: 新型小分子对人微血管内皮细胞增殖具有选择性细胞毒性公开(公告)号:US20070254894A1
公开(公告)日:2007-11-01
申请号:US11651406
申请日:2007-01-09
申请人: John Kane , Bradford Hirth , Christopher Yee , Mark Staveski , Hans-Peter Biemann , Marko Pregel
发明人: John Kane , Bradford Hirth , Christopher Yee , Mark Staveski , Hans-Peter Biemann , Marko Pregel
IPC分类号: A61K31/4709 , A61K31/497 , A61P9/00 , C07D215/38 , C07D243/08 , C07D401/14 , C07D413/14
CPC分类号: C07D401/12 , C07D401/14
摘要: Disclosed herein are angiogenesis inhibitors represented by formula (I) or formula (II): The variables for formulas (I) and (II) are defined herein.
摘要翻译: 本文公开了由式(I)或式(II)表示的血管生成抑制剂:式(I)和(II)的变量在本文中定义。
-
公开(公告)号:US20060173010A1
公开(公告)日:2006-08-03
申请号:US11292325
申请日:2005-12-01
申请人: Scott Sneddon , John Kane , Bradford Hirth , Fred Vinick , Shuang Qiao , Sharon Nahill , John Williams , Hans-Peter Biemann
发明人: Scott Sneddon , John Kane , Bradford Hirth , Fred Vinick , Shuang Qiao , Sharon Nahill , John Williams , Hans-Peter Biemann
IPC分类号: A61K31/498 , A61K31/497 , A61K31/4965 , A61K31/4439 , A61K31/4172 , C07D403/02
CPC分类号: A61K31/53 , C07D233/64 , C07D401/14 , C07D403/14
摘要: The present invention provides compounds which are modulators of TNF-α signaling and methods of use thereof for treating a patient having a TNF-α mediated condition. The compounds can be represented by the following structural formulas:
-
公开(公告)号:US07034031B2
公开(公告)日:2006-04-25
申请号:US10797244
申请日:2004-03-10
申请人: Scott F. Sneddon , John L. Kane , Bradford H. Hirth , Fred Vinick , Shuang Qiao , Sharon R. Nahill , John M. Williams , Hans-Peter Biemann
发明人: Scott F. Sneddon , John L. Kane , Bradford H. Hirth , Fred Vinick , Shuang Qiao , Sharon R. Nahill , John M. Williams , Hans-Peter Biemann
IPC分类号: C07D401/14 , C07D403/14 , A61K31/506 , A61P19/02 , A61P25/28
CPC分类号: A61K31/53 , C07D233/64 , C07D401/14 , C07D403/14
摘要: The present invention provides compounds which are modulators of TNF-α signaling and methods of use thereof for treating a patient having a TNF-α mediated condition. The compounds can be represented by the following structural formulas:
-
-
-
-